1 Introduction to Research & Analysis Reports
1.1 Oral Vaccine Adjuvants Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oral Vaccine Adjuvants Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oral Vaccine Adjuvants Overall Market Size
2.1 Global Oral Vaccine Adjuvants Market Size: 2022 VS 2029
2.2 Global Oral Vaccine Adjuvants Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Oral Vaccine Adjuvants Sales: 2018-2029
3 Company Landscape
3.1 Top Oral Vaccine Adjuvants Players in Global Market
3.2 Top Global Oral Vaccine Adjuvants Companies Ranked by Revenue
3.3 Global Oral Vaccine Adjuvants Revenue by Companies
3.4 Global Oral Vaccine Adjuvants Sales by Companies
3.5 Global Oral Vaccine Adjuvants Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Oral Vaccine Adjuvants Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Oral Vaccine Adjuvants Product Type
3.8 Tier 1, Tier 2 and Tier 3 Oral Vaccine Adjuvants Players in Global Market
3.8.1 List of Global Tier 1 Oral Vaccine Adjuvants Companies
3.8.2 List of Global Tier 2 and Tier 3 Oral Vaccine Adjuvants Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Oral Vaccine Adjuvants Market Size Markets, 2022 & 2029
4.1.2 Veterinary Vaccine Adjuvants
4.1.3 Human Vaccine Adjuvants
4.2 By Type – Global Oral Vaccine Adjuvants Revenue & Forecasts
4.2.1 By Type – Global Oral Vaccine Adjuvants Revenue, 2018-2023
4.2.2 By Type – Global Oral Vaccine Adjuvants Revenue, 2024-2029
4.2.3 By Type – Global Oral Vaccine Adjuvants Revenue Market Share, 2018-2029
4.3 By Type – Global Oral Vaccine Adjuvants Sales & Forecasts
4.3.1 By Type – Global Oral Vaccine Adjuvants Sales, 2018-2023
4.3.2 By Type – Global Oral Vaccine Adjuvants Sales, 2024-2029
4.3.3 By Type – Global Oral Vaccine Adjuvants Sales Market Share, 2018-2029
4.4 By Type – Global Oral Vaccine Adjuvants Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Oral Vaccine Adjuvants Market Size, 2022 & 2029
5.1.2 Research Application
5.1.3 Commercial Application
5.2 By Application – Global Oral Vaccine Adjuvants Revenue & Forecasts
5.2.1 By Application – Global Oral Vaccine Adjuvants Revenue, 2018-2023
5.2.2 By Application – Global Oral Vaccine Adjuvants Revenue, 2024-2029
5.2.3 By Application – Global Oral Vaccine Adjuvants Revenue Market Share, 2018-2029
5.3 By Application – Global Oral Vaccine Adjuvants Sales & Forecasts
5.3.1 By Application – Global Oral Vaccine Adjuvants Sales, 2018-2023
5.3.2 By Application – Global Oral Vaccine Adjuvants Sales, 2024-2029
5.3.3 By Application – Global Oral Vaccine Adjuvants Sales Market Share, 2018-2029
5.4 By Application – Global Oral Vaccine Adjuvants Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Oral Vaccine Adjuvants Market Size, 2022 & 2029
6.2 By Region – Global Oral Vaccine Adjuvants Revenue & Forecasts
6.2.1 By Region – Global Oral Vaccine Adjuvants Revenue, 2018-2023
6.2.2 By Region – Global Oral Vaccine Adjuvants Revenue, 2024-2029
6.2.3 By Region – Global Oral Vaccine Adjuvants Revenue Market Share, 2018-2029
6.3 By Region – Global Oral Vaccine Adjuvants Sales & Forecasts
6.3.1 By Region – Global Oral Vaccine Adjuvants Sales, 2018-2023
6.3.2 By Region – Global Oral Vaccine Adjuvants Sales, 2024-2029
6.3.3 By Region – Global Oral Vaccine Adjuvants Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Oral Vaccine Adjuvants Revenue, 2018-2029
6.4.2 By Country – North America Oral Vaccine Adjuvants Sales, 2018-2029
6.4.3 US Oral Vaccine Adjuvants Market Size, 2018-2029
6.4.4 Canada Oral Vaccine Adjuvants Market Size, 2018-2029
6.4.5 Mexico Oral Vaccine Adjuvants Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Oral Vaccine Adjuvants Revenue, 2018-2029
6.5.2 By Country – Europe Oral Vaccine Adjuvants Sales, 2018-2029
6.5.3 Germany Oral Vaccine Adjuvants Market Size, 2018-2029
6.5.4 France Oral Vaccine Adjuvants Market Size, 2018-2029
6.5.5 U.K. Oral Vaccine Adjuvants Market Size, 2018-2029
6.5.6 Italy Oral Vaccine Adjuvants Market Size, 2018-2029
6.5.7 Russia Oral Vaccine Adjuvants Market Size, 2018-2029
6.5.8 Nordic Countries Oral Vaccine Adjuvants Market Size, 2018-2029
6.5.9 Benelux Oral Vaccine Adjuvants Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Oral Vaccine Adjuvants Revenue, 2018-2029
6.6.2 By Region – Asia Oral Vaccine Adjuvants Sales, 2018-2029
6.6.3 China Oral Vaccine Adjuvants Market Size, 2018-2029
6.6.4 Japan Oral Vaccine Adjuvants Market Size, 2018-2029
6.6.5 South Korea Oral Vaccine Adjuvants Market Size, 2018-2029
6.6.6 Southeast Asia Oral Vaccine Adjuvants Market Size, 2018-2029
6.6.7 India Oral Vaccine Adjuvants Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Oral Vaccine Adjuvants Revenue, 2018-2029
6.7.2 By Country – South America Oral Vaccine Adjuvants Sales, 2018-2029
6.7.3 Brazil Oral Vaccine Adjuvants Market Size, 2018-2029
6.7.4 Argentina Oral Vaccine Adjuvants Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Oral Vaccine Adjuvants Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Oral Vaccine Adjuvants Sales, 2018-2029
6.8.3 Turkey Oral Vaccine Adjuvants Market Size, 2018-2029
6.8.4 Israel Oral Vaccine Adjuvants Market Size, 2018-2029
6.8.5 Saudi Arabia Oral Vaccine Adjuvants Market Size, 2018-2029
6.8.6 UAE Oral Vaccine Adjuvants Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 SEPPIC
7.1.1 SEPPIC Company Summary
7.1.2 SEPPIC Business Overview
7.1.3 SEPPIC Oral Vaccine Adjuvants Major Product Offerings
7.1.4 SEPPIC Oral Vaccine Adjuvants Sales and Revenue in Global (2018-2023)
7.1.5 SEPPIC Key News & Latest Developments
7.2 SDA BIO
7.2.1 SDA BIO Company Summary
7.2.2 SDA BIO Business Overview
7.2.3 SDA BIO Oral Vaccine Adjuvants Major Product Offerings
7.2.4 SDA BIO Oral Vaccine Adjuvants Sales and Revenue in Global (2018-2023)
7.2.5 SDA BIO Key News & Latest Developments
7.3 Croda International
7.3.1 Croda International Company Summary
7.3.2 Croda International Business Overview
7.3.3 Croda International Oral Vaccine Adjuvants Major Product Offerings
7.3.4 Croda International Oral Vaccine Adjuvants Sales and Revenue in Global (2018-2023)
7.3.5 Croda International Key News & Latest Developments
7.4 SPI Pharma
7.4.1 SPI Pharma Company Summary
7.4.2 SPI Pharma Business Overview
7.4.3 SPI Pharma Oral Vaccine Adjuvants Major Product Offerings
7.4.4 SPI Pharma Oral Vaccine Adjuvants Sales and Revenue in Global (2018-2023)
7.4.5 SPI Pharma Key News & Latest Developments
7.5 Phibro Animal Health Corporation
7.5.1 Phibro Animal Health Corporation Company Summary
7.5.2 Phibro Animal Health Corporation Business Overview
7.5.3 Phibro Animal Health Corporation Oral Vaccine Adjuvants Major Product Offerings
7.5.4 Phibro Animal Health Corporation Oral Vaccine Adjuvants Sales and Revenue in Global (2018-2023)
7.5.5 Phibro Animal Health Corporation Key News & Latest Developments
7.6 Tj Kaiwei
7.6.1 Tj Kaiwei Company Summary
7.6.2 Tj Kaiwei Business Overview
7.6.3 Tj Kaiwei Oral Vaccine Adjuvants Major Product Offerings
7.6.4 Tj Kaiwei Oral Vaccine Adjuvants Sales and Revenue in Global (2018-2023)
7.6.5 Tj Kaiwei Key News & Latest Developments
7.7 Novavax
7.7.1 Novavax Company Summary
7.7.2 Novavax Business Overview
7.7.3 Novavax Oral Vaccine Adjuvants Major Product Offerings
7.7.4 Novavax Oral Vaccine Adjuvants Sales and Revenue in Global (2018-2023)
7.7.5 Novavax Key News & Latest Developments
7.8 Zhuoyue
7.8.1 Zhuoyue Company Summary
7.8.2 Zhuoyue Business Overview
7.8.3 Zhuoyue Oral Vaccine Adjuvants Major Product Offerings
7.8.4 Zhuoyue Oral Vaccine Adjuvants Sales and Revenue in Global (2018-2023)
7.8.5 Zhuoyue Key News & Latest Developments
7.9 Aphios
7.9.1 Aphios Company Summary
7.9.2 Aphios Business Overview
7.9.3 Aphios Oral Vaccine Adjuvants Major Product Offerings
7.9.4 Aphios Oral Vaccine Adjuvants Sales and Revenue in Global (2018-2023)
7.9.5 Aphios Key News & Latest Developments
7.10 GSK
7.10.1 GSK Company Summary
7.10.2 GSK Business Overview
7.10.3 GSK Oral Vaccine Adjuvants Major Product Offerings
7.10.4 GSK Oral Vaccine Adjuvants Sales and Revenue in Global (2018-2023)
7.10.5 GSK Key News & Latest Developments
7.11 CSL
7.11.1 CSL Company Summary
7.11.2 CSL Oral Vaccine Adjuvants Business Overview
7.11.3 CSL Oral Vaccine Adjuvants Major Product Offerings
7.11.4 CSL Oral Vaccine Adjuvants Sales and Revenue in Global (2018-2023)
7.11.5 CSL Key News & Latest Developments
7.12 Brenntag Biosector
7.12.1 Brenntag Biosector Company Summary
7.12.2 Brenntag Biosector Oral Vaccine Adjuvants Business Overview
7.12.3 Brenntag Biosector Oral Vaccine Adjuvants Major Product Offerings
7.12.4 Brenntag Biosector Oral Vaccine Adjuvants Sales and Revenue in Global (2018-2023)
7.12.5 Brenntag Biosector Key News & Latest Developments
7.13 SEPPIC
7.13.1 SEPPIC Company Summary
7.13.2 SEPPIC Oral Vaccine Adjuvants Business Overview
7.13.3 SEPPIC Oral Vaccine Adjuvants Major Product Offerings
7.13.4 SEPPIC Oral Vaccine Adjuvants Sales and Revenue in Global (2018-2023)
7.13.5 SEPPIC Key News & Latest Developments
7.14 SPI Pharma
7.14.1 SPI Pharma Company Summary
7.14.2 SPI Pharma Business Overview
7.14.3 SPI Pharma Oral Vaccine Adjuvants Major Product Offerings
7.14.4 SPI Pharma Oral Vaccine Adjuvants Sales and Revenue in Global (2018-2023)
7.14.5 SPI Pharma Key News & Latest Developments
7.15 Novavax
7.15.1 Novavax Company Summary
7.15.2 Novavax Business Overview
7.15.3 Novavax Oral Vaccine Adjuvants Major Product Offerings
7.15.4 Novavax Oral Vaccine Adjuvants Sales and Revenue in Global (2018-2023)
7.15.5 Novavax Key News & Latest Developments
7.16 Avanti Polar Lipids
7.16.1 Avanti Polar Lipids Company Summary
7.16.2 Avanti Polar Lipids Business Overview
7.16.3 Avanti Polar Lipids Oral Vaccine Adjuvants Major Product Offerings
7.16.4 Avanti Polar Lipids Oral Vaccine Adjuvants Sales and Revenue in Global (2018-2023)
7.16.5 Avanti Polar Lipids Key News & Latest Developments
7.17 Aphios
7.17.1 Aphios Company Summary
7.17.2 Aphios Business Overview
7.17.3 Aphios Oral Vaccine Adjuvants Major Product Offerings
7.17.4 Aphios Oral Vaccine Adjuvants Sales and Revenue in Global (2018-2023)
7.17.5 Aphios Key News & Latest Developments
8 Global Oral Vaccine Adjuvants Production Capacity, Analysis
8.1 Global Oral Vaccine Adjuvants Production Capacity, 2018-2029
8.2 Oral Vaccine Adjuvants Production Capacity of Key Manufacturers in Global Market
8.3 Global Oral Vaccine Adjuvants Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Oral Vaccine Adjuvants Supply Chain Analysis
10.1 Oral Vaccine Adjuvants Industry Value Chain
10.2 Oral Vaccine Adjuvants Upstream Market
10.3 Oral Vaccine Adjuvants Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Oral Vaccine Adjuvants Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界の経口ワクチンアジュバント市場予測2023-2029：動物用ワクチンアジュバント、人間用ワクチンアジュバント |
| 【英語タイトル】Oral Vaccine Adjuvants Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5441 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：115 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医療機器＆消耗品 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の経口ワクチンアジュバント市場規模と予測を収録しています。・世界の経口ワクチンアジュバント市場：売上、2018年-2023年、2024年-2029年 ・世界の経口ワクチンアジュバント市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の経口ワクチンアジュバント市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「動物用ワクチンアジュバント」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 経口ワクチンアジュバントのグローバル主要企業は、SEPPIC、 SDA BIO、 Croda International、 SPI Pharma、 Phibro Animal Health Corporation、 Tj Kaiwei、 Novavax、 Zhuoyue、 Aphios、 GSK、 CSL、 Brenntag Biosector、 SEPPIC、 SPI Pharma、 Novavax、 Avanti Polar Lipids、 Aphiosなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、経口ワクチンアジュバントのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の経口ワクチンアジュバント市場：タイプ別、2018年-2023年、2024年-2029年 世界の経口ワクチンアジュバント市場：タイプ別市場シェア、2022年 ・動物用ワクチンアジュバント、人間用ワクチンアジュバント 世界の経口ワクチンアジュバント市場：用途別、2018年-2023年、2024年-2029年 世界の経口ワクチンアジュバント市場：用途別市場シェア、2022年 ・研究用、商業用 世界の経口ワクチンアジュバント市場：地域・国別、2018年-2023年、2024年-2029年 世界の経口ワクチンアジュバント市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における経口ワクチンアジュバントのグローバル売上、2018年-2023年 ・主要企業における経口ワクチンアジュバントのグローバル売上シェア、2022年 ・主要企業における経口ワクチンアジュバントのグローバル販売量、2018年-2023年 ・主要企業における経口ワクチンアジュバントのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 SEPPIC、 SDA BIO、 Croda International、 SPI Pharma、 Phibro Animal Health Corporation、 Tj Kaiwei、 Novavax、 Zhuoyue、 Aphios、 GSK、 CSL、 Brenntag Biosector、 SEPPIC、 SPI Pharma、 Novavax、 Avanti Polar Lipids、 Aphios ************************************************************* ・調査・分析レポートの概要 経口ワクチンアジュバント市場の定義 市場セグメント 世界の経口ワクチンアジュバント市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の経口ワクチンアジュバント市場規模 世界の経口ワクチンアジュバント市場規模：2022年 VS 2029年 世界の経口ワクチンアジュバント市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの経口ワクチンアジュバントの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の経口ワクチンアジュバント製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：動物用ワクチンアジュバント、人間用ワクチンアジュバント 経口ワクチンアジュバントのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：研究用、商業用 経口ワクチンアジュバントの用途別グローバル売上・予測 ・地域別市場分析 地域別経口ワクチンアジュバント市場規模 2022年と2029年 地域別経口ワクチンアジュバント売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） SEPPIC、 SDA BIO、 Croda International、 SPI Pharma、 Phibro Animal Health Corporation、 Tj Kaiwei、 Novavax、 Zhuoyue、 Aphios、 GSK、 CSL、 Brenntag Biosector、 SEPPIC、 SPI Pharma、 Novavax、 Avanti Polar Lipids、 Aphios ... |
Vaccine adjuvants (Adjuvant) are a class of substances that can non-specifically change or enhance the body’s specific immune response to antigens and play an auxiliary role. Adjuvants can induce the body to produce a long-term and efficient specific immune response, improve the body’s protective ability, and at the same time reduce the dosage of immune substances and reduce the production cost of vaccines.
This report aims to provide a comprehensive presentation of the global market for Oral Vaccine Adjuvants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Vaccine Adjuvants. This report contains market size and forecasts of Oral Vaccine Adjuvants in global, including the following market information:
Global Oral Vaccine Adjuvants Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Oral Vaccine Adjuvants Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Oral Vaccine Adjuvants companies in 2022 (%)
The global Oral Vaccine Adjuvants market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Veterinary Vaccine Adjuvants Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Oral Vaccine Adjuvants include SEPPIC, SDA BIO, Croda International, SPI Pharma, Phibro Animal Health Corporation, Tj Kaiwei, Novavax, Zhuoyue and Aphios, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oral Vaccine Adjuvants manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oral Vaccine Adjuvants Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Oral Vaccine Adjuvants Market Segment Percentages, by Type, 2022 (%)
Veterinary Vaccine Adjuvants
Human Vaccine Adjuvants
Global Oral Vaccine Adjuvants Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Oral Vaccine Adjuvants Market Segment Percentages, by Application, 2022 (%)
Research Application
Commercial Application
Global Oral Vaccine Adjuvants Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Oral Vaccine Adjuvants Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oral Vaccine Adjuvants revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Oral Vaccine Adjuvants revenues share in global market, 2022 (%)
Key companies Oral Vaccine Adjuvants sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Oral Vaccine Adjuvants sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
SEPPIC
SDA BIO
Croda International
SPI Pharma
Phibro Animal Health Corporation
Tj Kaiwei
Novavax
Zhuoyue
Aphios
GSK
CSL
Brenntag Biosector
SEPPIC
SPI Pharma
Novavax
Avanti Polar Lipids
Aphios
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oral Vaccine Adjuvants, market overview.
Chapter 2: Global Oral Vaccine Adjuvants market size in revenue and volume.
Chapter 3: Detailed analysis of Oral Vaccine Adjuvants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oral Vaccine Adjuvants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Oral Vaccine Adjuvants capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界の経口ワクチンアジュバント市場予測2023-2029：動物用ワクチンアジュバント、人間用ワクチンアジュバント] (コード：MMG23JU5441)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の経口ワクチンアジュバント市場予測2023-2029：動物用ワクチンアジュバント、人間用ワクチンアジュバント]についてメールでお問い合わせ |
